AMBUBC Stock Overview
A medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Ambu A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 111.75 |
| 52 Week High | DKK 150.95 |
| 52 Week Low | DKK 103.60 |
| Beta | 0.81 |
| 1 Month Change | -3.20% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -34.52% |
| 5 Year Change | -1.19% |
| Change since IPO | 773.05% |
Recent News & Updates
Recent updates
Shareholder Returns
| AMBUBC | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | -1.2% | -1.5% |
| 1Y | n/a | -8.9% | 3.5% |
Return vs Industry: Insufficient data to determine how AMBUBC performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how AMBUBC performed against the UK Market.
Price Volatility
| AMBUBC volatility | |
|---|---|
| AMBUBC Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 10.6% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: AMBUBC's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine AMBUBC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1937 | 5,196 | Britt Jensen | www.ambu.com |
Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Ambu A/S Fundamentals Summary
| AMBUBC fundamental statistics | |
|---|---|
| Market cap | DKK 28.56b |
| Earnings (TTM) | DKK 235.00m |
| Revenue (TTM) | DKK 5.39b |
121.5x
P/E Ratio5.3x
P/S RatioIs AMBUBC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMBUBC income statement (TTM) | |
|---|---|
| Revenue | DKK 5.39b |
| Cost of Revenue | DKK 2.19b |
| Gross Profit | DKK 3.20b |
| Other Expenses | DKK 2.97b |
| Earnings | DKK 235.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 30, 2025
| Earnings per share (EPS) | 0.88 |
| Gross Margin | 59.38% |
| Net Profit Margin | 4.36% |
| Debt/Equity Ratio | 0% |
How did AMBUBC perform over the long term?
See historical performance and comparisonDividends
0.4%
Current Dividend Yield43%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 10:49 |
| End of Day Share Price | 2024/11/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ambu A/S is covered by 16 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Healy | Berenberg |
| Alexander Berglund | BofA Global Research |
| Lars Topholm | Carnegie Investment Bank AB |